Stay updated on Benralizumab in Chronic Urticaria Clinical Trial
Sign up to get notified when there's something new on the Benralizumab in Chronic Urticaria Clinical Trial page.

Latest updates to the Benralizumab in Chronic Urticaria Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedThe page shows a new revision label v3.5.4 replacing the previous v3.5.3. This indicates a minor update to the page's revision history metadata rather than substantive content changes.SummaryDifference0.0%

- Check25 days agoChange DetectedNo additions or deletions were recorded; the page content and structure appear unchanged. There are no new elements affecting the page's purpose.SummaryDifference0.0%

- Check32 days agoChange DetectedThe page's revision metadata was updated from v3.5.2 to v3.5.3, signaling an incremental update to the study record documentation.SummaryDifference0.1%

- Check46 days agoChange DetectedAdded revision: v3.5.2; removed revision: v3.5.0.SummaryDifference0.0%

- Check54 days agoChange DetectedIQVIA Pty Ltd was added as a collaborator and Iqvia Pty Ltd was removed from the Collaborators and Investigators section. This updates the official list of organizations involved in the study.SummaryDifference0.0%

- Check75 days agoChange DetectedRevision v3.5.0 was added and Revision v3.4.3 was removed.SummaryDifference0.0%

Stay in the know with updates to Benralizumab in Chronic Urticaria Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Benralizumab in Chronic Urticaria Clinical Trial page.